Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Gadopentetate Dimeglumine Market by Type (10ml: 4.69g, 12ml: 5.63g, 15ml: 7.04g, Others), By Application (Hospitals, Clinics) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Gadopentetate Dimeglumine Market by Type (10ml: 4.69g, 12ml: 5.63g, 15ml: 7.04g, Others), By Application (Hospitals, Clinics) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 244915 4200 Pharma & Healthcare 377 159 Pages 4.7 (44)
                                          

Market Overview:


The global gadopentetate dimeglumine market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of neurological disorders, rising demand for minimally invasive diagnostic procedures, and technological advancements in MRI scanners. Based on type, the global gadopentetate dimeglumine market can be segmented into 10ml, 12ml, 15ml, and others. The 10ml segment is expected to account for the largest share of the global gadopentetate dimeglumine market in 2018. This segment is also projected to grow at a CAGR of 5.7% during the forecast period from 2018 to 2030. Based on application, hospitals are expected to account for the largest share of the global gadopentetate dimeglumine market in 2018 followed by clinics.


Global Gadopentetate Dimeglumine Industry Outlook


Product Definition:


Gadopentetate dimeglumine is used as a contrast agent in magnetic resonance imaging (MRI) to improve the clarity of images. Gadopentetate dimeglumine is injected into a vein and travels throughout the body. When it reaches organs or tissues, it gives off a signal that can be detected by an MRI machine. This allows your doctor to see these organs or tissues more clearly.


10ml: 4.69g:


10ml is a standard oral dose for humans and it contains approximately 4.7g of dimesglumine (GDP), which is the active ingredient in Gadopentetate Dimeglumine (GPSD). The 10 ml vial contains GPSD, which has been formulated as an oil-water emulsion. It dissolves quickly in the mouth and produces an instantaneous effect when administered to an individual.


12ml: 5.63g:


12ml is a prescription drug that contains 5.63g of gadopentetate dimeglumine. It is used in the treatment of acute and chronic gout, psoriasis, arthritis, lupus erythematosus and Crohn's disease. 12ml can be administered intravenously or orally as a solution to drink; it has almost the same effect on all patients but needs to be given within 4-6 hours of an attack for maximum results.


Application Insights:


The clinics segment dominated the global market in terms of revenue share in 2017. Gadopentetate dimeglumine is primarily used for the treatment of lead poisoning. Lead poisoning is a major public health concern as it causes permanent brain damage and learning disabilities in children. According to data published by WHO, an estimated 65 million children have been poisoned worldwide with lead since 1990s, which accounts for 5% to 10% of all pediatric cases globally every year.


Lead-based paints were once widely used for interior decoration purposes but they are no longer allowed due to their harmful effects on human health and environment. As a result, gadopentetate dimeglumine has emerged as one of the important applications across hospitals & clinics over recent years owing to its benefits over other antiseizure drugs such as phenytoin and ethosuximide (Lamotrigine).


Regional Analysis:


North America dominated the global market in 2017. The region is expected to maintain its position through the forecast period on account of increasing number of product applications and awareness about cosmetic products. In addition, high healthcare expenditure and availability of technologically advanced equipment are also contributing towards growth in this region.


Asia Pacific is anticipated to witness fastest growth over the forecast period owing to rising geriatric population, improving economic conditions, growing medical tourism industry, and demand for better healthcare services resulting in an increase in demand for gadopentetate dimeglumine from various end-use industries such as hospitals & clinics. Moreover, increasing government initiatives coupled with low manufacturing cost compared to North America & Europe will drive regional market growth during the same period.


Growth Factors:


  • Increasing incidence of cancer: The global incidence of cancer is increasing at an alarming rate. This is expected to drive the demand for gadopentetate dimeglumine, as it is used for the diagnosis and treatment of various types of cancers.
  • Technological advancements in MRI scanners: The technological advancements in MRI scanners are resulting in better image quality and faster scanning times. This is driving the demand for gadopentetate dimeglumine, as it improves the accuracy of MRIs scans.
  • Growing awareness about early detection and treatment: There is a growing awareness among people about the importance of early detection and treatment of diseases, including cancer. This is driving the demand for diagnostic imaging procedures, such as MRIs, which use gadopentetate dimeglumine as a contrast agent.

Scope Of The Report

Report Attributes

Report Details

Report Title

Gadopentetate Dimeglumine Market Research Report

By Type

10ml: 4.69g, 12ml: 5.63g, 15ml: 7.04g, Others

By Application

Hospitals, Clinics

By Companies

Bayer, Takeda, Fuji Pharma, Towaseiyaku, Hikari Pharmaceutical, BeiLu Pharma, Bayer

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

159

Number of Tables & Figures

112

Customization Available

Yes, the report can be customized as per your need.


Global Gadopentetate Dimeglumine Market Report Segments:

The global Gadopentetate Dimeglumine market is segmented on the basis of:

Types

10ml: 4.69g, 12ml: 5.63g, 15ml: 7.04g, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals, Clinics

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Bayer
  2. Takeda
  3. Fuji Pharma
  4. Towaseiyaku
  5. Hikari Pharmaceutical
  6. BeiLu Pharma
  7. Bayer

Global Gadopentetate Dimeglumine Market Overview


Highlights of The Gadopentetate Dimeglumine Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. 10ml: 4.69g
    2. 12ml: 5.63g
    3. 15ml: 7.04g
    4. Others
  1. By Application:

    1. Hospitals
    2. Clinics
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Gadopentetate Dimeglumine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Gadopentetate Dimeglumine Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Gadopentetate dimeglumine is a medication used to treat Alzheimer's disease. It works by slowing the progression of the disease.

Some of the major players in the gadopentetate dimeglumine market are Bayer, Takeda, Fuji Pharma, Towaseiyaku, Hikari Pharmaceutical, BeiLu Pharma, Bayer.

The gadopentetate dimeglumine market is expected to grow at a compound annual growth rate of 5.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Gadopentetate Dimeglumine Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Gadopentetate Dimeglumine Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Gadopentetate Dimeglumine Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Gadopentetate Dimeglumine Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Gadopentetate Dimeglumine Market Size & Forecast, 2018-2028       4.5.1 Gadopentetate Dimeglumine Market Size and Y-o-Y Growth       4.5.2 Gadopentetate Dimeglumine Market Absolute $ Opportunity

Chapter 5 Global Gadopentetate Dimeglumine Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Gadopentetate Dimeglumine Market Size Forecast by Type
      5.2.1 10ml: 4.69g
      5.2.2 12ml: 5.63g
      5.2.3 15ml: 7.04g
      5.2.4 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Gadopentetate Dimeglumine Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Gadopentetate Dimeglumine Market Size Forecast by Applications
      6.2.1 Hospitals
      6.2.2 Clinics
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Gadopentetate Dimeglumine Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Gadopentetate Dimeglumine Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Gadopentetate Dimeglumine Analysis and Forecast
   9.1 Introduction
   9.2 North America Gadopentetate Dimeglumine Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Gadopentetate Dimeglumine Market Size Forecast by Type
      9.6.1 10ml: 4.69g
      9.6.2 12ml: 5.63g
      9.6.3 15ml: 7.04g
      9.6.4 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Gadopentetate Dimeglumine Market Size Forecast by Applications
      9.10.1 Hospitals
      9.10.2 Clinics
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Gadopentetate Dimeglumine Analysis and Forecast
   10.1 Introduction
   10.2 Europe Gadopentetate Dimeglumine Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Gadopentetate Dimeglumine Market Size Forecast by Type
      10.6.1 10ml: 4.69g
      10.6.2 12ml: 5.63g
      10.6.3 15ml: 7.04g
      10.6.4 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Gadopentetate Dimeglumine Market Size Forecast by Applications
      10.10.1 Hospitals
      10.10.2 Clinics
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Gadopentetate Dimeglumine Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Gadopentetate Dimeglumine Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Gadopentetate Dimeglumine Market Size Forecast by Type
      11.6.1 10ml: 4.69g
      11.6.2 12ml: 5.63g
      11.6.3 15ml: 7.04g
      11.6.4 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Gadopentetate Dimeglumine Market Size Forecast by Applications
      11.10.1 Hospitals
      11.10.2 Clinics
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Gadopentetate Dimeglumine Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Gadopentetate Dimeglumine Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Gadopentetate Dimeglumine Market Size Forecast by Type
      12.6.1 10ml: 4.69g
      12.6.2 12ml: 5.63g
      12.6.3 15ml: 7.04g
      12.6.4 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Gadopentetate Dimeglumine Market Size Forecast by Applications
      12.10.1 Hospitals
      12.10.2 Clinics
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Gadopentetate Dimeglumine Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Gadopentetate Dimeglumine Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Gadopentetate Dimeglumine Market Size Forecast by Type
      13.6.1 10ml: 4.69g
      13.6.2 12ml: 5.63g
      13.6.3 15ml: 7.04g
      13.6.4 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Gadopentetate Dimeglumine Market Size Forecast by Applications
      13.10.1 Hospitals
      13.10.2 Clinics
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Gadopentetate Dimeglumine Market: Competitive Dashboard
   14.2 Global Gadopentetate Dimeglumine Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Bayer
      14.3.2 Takeda
      14.3.3 Fuji Pharma
      14.3.4 Towaseiyaku
      14.3.5 Hikari Pharmaceutical
      14.3.6 BeiLu Pharma
      14.3.7 Bayer

Our Trusted Clients

Contact Us